The genetic predisposition to produce high levels of TGF-β1 impacts on the severity of eclampsia/pre-eclampsia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 8, 2007, Pages 903-908

  Stanczuk, Grazyna A ^a,c,d   McCoy, Melanie J ^b   Hutchinson, Ian V ^b   Sibanda, Elopy N ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIV OF ZIMBABWE MEDICAL SCHOOL   (Zimbabwe)

Author keywords

Eclampsia pre eclampsia; TGF 1 gene polymorphism; Zimbabwe

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AMPLIFICATION REFRACTORY MUTATION SYSTEM; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DNA POLYMORPHISM; ECLAMPSIA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; IMMUNOGENICITY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ECLAMPSIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; SEVERITY OF ILLNESS INDEX; SYNDROME; TRANSFORMING GROWTH FACTOR BETA1; ZIMBABWE;

EID: 34547225468     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701416945     Document Type: Article

References (47)

1. Roberts JM, Taylor RN, Musci TJ, Rodgers DM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161:1200-4.
2. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertension. 1991;4:700-8.
3. Roberts JM, Redman CWR. Pre-eclampsia: more than PIH. Lancet. 1993;341:1447-51.
4. Robertson WB, Brosens I, Dixon HG. The pathological response of the vessels of the placental bed to hypertensive pregnancy. 1967 J Pathol Bacteriol 581-92.
5. Lim K-H, Zhou Y, Janatpour M, McMaster M, Bass K, Chun S-H, et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol. 1997;151:1809-18.
6. Wilczynski JR, Tchorzewski H, Glowacka E, Banasik M, Lewkowicz P, Szpakowski M, et al. Cytokine secretion by decidual lymphocytes in transient hypertension of pregnancy and pre-eclampsia. Mediators Inflamm. 2002;11:105-11.
7. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997;37:240-9.
8. Hutchinson IV, Turner DM, Sankaran D, Awad MR, Sinnott PJ. Influence of cytokine genotypes on allograft rejection. Transplant Proc. 1998;30:862-3.
9. Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LM, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ. 2005;331:87710.
10. Carr DB, Epplein M, Johnson CO, Easterling TR, Critchlow CW. A sister's risk: family history as a predictor of preeclampsia. Am J Obstet Gynecol. 2005;193:965-72.
11. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol. 1996;104:154-9.
12. Daher S, Sass N, Oliveira LG, Mattar R. Cytokine genotyping in preeclampsia. Am J Reprod Immunol. 2006;55:130-5.
13. Kaiser T, Grehan M, Brennecke SP, Moses EK. Association of the TNF2 allele with eclampsia. Gynecol Obstet Invest. 2004;57:204-9.
14. Saarela T, Hiltunen M, Helisalmi S, Heinonen S, Laakso M. Tumour necrosis factor-alpha gene haplotype is associated with pre-eclampsia. Mol Hum Reprod. 2005;11:437-40.
15. de Groot CJ, Jansen MW, Bertina RM, Schonkeren JJ, Helmerhorst FM, Huizinga TW. Interleukin 10-2849AA genotype protects against pre-eclampsia. Genes Immun. 2004;5:313-4.
16. Heffler LA, Tempfer CB, Gregg AR. Polymorphisms within the interleukin-1β gene cluster and preeclampsia. Obstet Gynecol. 2001;97:664-8.
17. Pfab T, Chen YP, Slowinski T, Richter CM, Godes M, Arck PC, et al. Impact of genes related to immune tolerance and inflammation (tumour necrosis factor-alpha, interleukin-6) on blood pressure, protein excretion and oedema in pregnancy. J Hypertens. 2005;23:2187-91.
18. Graham CH, Lala PK. Mechanism of control of trophoblast invasion in situ. J Cell Physiol. 1991;148:228-34.
19. Caniggia I, Letarte M, Post M, Lye SJ. Regulation of trophoblast differentiation by TGF-1 and TGF-3 via endoglin. Placenta. 1996;17:A36.
20. Lala K, Lysiak JJ. Role of locally produced growth factors in human placental growth and invasion with special reference to transforming growth factors. In: Hunt JS, editor. Immunobiology of Reproduction. New York: Springer-Verlag; 1994. p. 57-81.
21. Graham CH, Lysiak JJ, McCrae KR, Lala PK. Localisation of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod. 1992;46:561-72.
22. Morrish DW, Bhardwaj D, Paras MT. Transforming growth factor β1 inhibits placental differentiation and human chorionic gonadotropin and human placental lactogen secretion. Endocrinology. 1991;129:22-6.
23. Luo S, Yu H, Wu D, Peng C. Transforming growth factor-β1 inhibits steroidogenesis in human trophoblast cells. Mol Hum Reprod. 2002;8:318-25.
24. Bielecki DA, Klonowska-Dziatkiewicz E, Jarocki S, Urban J. Growth factors in pregnancy complications with preeclampsia. Ginekol Pol. 2002;73:422-9.
25. Benian A, Madazli R, Aksu F, Uzun H, Aydin S. Plasma and placental levels of interleukine-10, transforming growth factor-beta 1, and epithelial-cadherin in preeclampsia. Obstet Gynecol. 2002;100:327-31.
26. Enquobahrie DA, Williams MA, Qiu C, Woelk GB, Mahomed K. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women. J Matern Fetal Neonatal Med. 2005;17:343-8.
27. Muy-Rivera M, Sanchez SE, Vadachkoria S, Qiu C, Bazul V, Williams MA. Transforming growth factor-beta1 (TGF-beta1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation. Am J Hypertens. 2004;17:334-8.
28. Madazli R, Aydin S, Uludag S, Vildan O, Tolun N. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand. 2003;82:797-802.
29. Naicker T, Khedun SM, Moodley J. Transforming growth factor beta levels in platelet depleted plasma in African women with pre-eclampsia. J Obstet Gynaecol. 2002;22:279-82.
30. Ayatollahi M, Geramizadeh B, Samsami A. Transforming growth factor beta-1 influence on fetal allografts during pregnancy. Transplant Proc. 2005;37:4603-4.
31. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642-9.
32. Laviades C, Varo N, Diez J. Transforming growth factor beta in hypertensives with cardiorenal damage. Hypertension. 2000;36:517-22.
33. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, et al. Transforming growth factor-β 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA. 2000;97:3479-84.
34. Russo LM, Osicka TM, Bonnet F, Jerums G, Comper WD. Albuminuria in hypertension is linked to altered lysosomal activity and TGF-beta 1 expression. Hypertension. 2002;39:281-6.
35. Derhaschnig U, Shehata M, Herkner H, Bur A, Woisetschlager C, Laggner AN, et al. Increased levels of transforming growth factor-beta 1 in essential hypertension. Am J Hypertens. 2002;15:207-11.
36. Noble NA, Border WA. Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target? Sem Nephrol. 1997;17:455-66.
37. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, et al. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int. 1996;49:461-9.
38. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β 1 gene polymorphisms. Transpl Immunol. 1999;7:127-8.
39. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott P, Hutchinson IV. Genomic variation in the transforming growth factor-β1 gene. Transplantation. 1998;66:1014-20.
40. Border WA. Transforming growth factor-beta and the pathogenesis of glomerular diseases. Curr Opin Nephrol Hypertens. 1994;3:54-8.
41. Taniguchi Y, Yorioka N, Masaki T, Yamashita K, Ito T, Ueda H, et al. Role of transforming growth factor-beta 1 in glomerulonephritis. J Int Med Res. 1997;25:71-80.
42. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, et al. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest. 1993;68:154-63.
43. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int. 1994;45:916-27.
44. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, et al. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int. 1996;49:461-9.
45. Gant NF, Chand S, Worley RJ, Whalley PJ, Crosby UD, MacDonald PC. A clinical test useful for predicting the development of acute hypertension in pregnancy. Am J Obstet Gynecol. 1974;120:1-7.
46. Baker PN, Broughton PF, Symonds EM. Platelet angiotensin II binding sites in normotensive and hypertensive women. Br J Obstet Gynaecol. 1991;98:436-40.
47. Daher S, Sass N, Oliveira LG, Mattar R. Cytokine genotyping in preeclampsia. Am J Reprod Immunol. 2006;55:130-5.